These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8743765)

  • 1. Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries.
    Fals-Stewart W
    J Subst Abuse; 1996; 8(1):1-17. PubMed ID: 8743765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation.
    Gillen RW; Kranzler HR; Kadden RM; Weidenman MA
    J Subst Abuse Treat; 1991; 8(4):247-51. PubMed ID: 1664866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module.
    Grohman K; Fals-Stewart W
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):200-7. PubMed ID: 15301637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive capacity in female adolescent substance abusers.
    Tarter RE; Mezzich AC; Hsieh YC; Parks SM
    Drug Alcohol Depend; 1995 Jul; 39(1):15-21. PubMed ID: 7587969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using subtests of the Brain Age Quotient to screen for cognitive deficits among substance abusers.
    Fals-Stewart W
    Percept Mot Skills; 1992 Aug; 75(1):244-6. PubMed ID: 1528674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of patients' cognitive status and therapists' ratings of psychological distress among psychoactive substance users in long-term residential treatment.
    Fals-Stewart W; Lucente S; Shanahan T; Brown L
    J Subst Abuse; 1995; 7(2):205-22. PubMed ID: 7580230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity issues in using the Millon-II with substance abusers.
    Bishop DR
    Psychol Rep; 1993 Aug; 73(1):27-33. PubMed ID: 8367567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of neuropsychological impairment among substance-abusing patients: accuracy of the neurobehavioral cognitive status examination.
    Fals-Stewart W
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):269-76. PubMed ID: 9260075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of substance abuse on visuographic function.
    Amir T; Bahri T
    Percept Mot Skills; 1994 Feb; 78(1):235-41. PubMed ID: 8177664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive efficiency in alcoholics and polysubstance abusers.
    Nixon SJ; Paul R; Phillips M
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1414-20. PubMed ID: 9802522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological deficits and opiate abuse.
    Davis PE; Liddiard H; McMillan TM
    Drug Alcohol Depend; 2002 Jun; 67(1):105-8. PubMed ID: 12062785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principles of withdrawal from illicit drugs during inpatient therapy].
    Singer W; Breuer M
    Internist (Berl); 1999 Jun; 40(6):634-9. PubMed ID: 10420318
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia.
    Joyal CC; Hallé P; Lapierre D; Hodgins S
    Schizophr Res; 2003 Oct; 63(3):297-9. PubMed ID: 12957709
    [No Abstract]   [Full Text] [Related]  

  • 16. Note on comparability of MicroCog test forms.
    Lopez SJ; Edwards LM; Floyd RK; Magyar-Moe J; Rehfeldt JD; Ryder JA
    Percept Mot Skills; 2001 Dec; 93(3):825-8. PubMed ID: 11806607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study.
    Stowell RJ; Estroff TW
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1036-40. PubMed ID: 1429401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability to counselors to detect cognitive impairment among substance-abusing patients: an examination of diagnostic efficiency.
    Fals-Stewart W
    Exp Clin Psychopharmacol; 1997 Feb; 5(1):39-50. PubMed ID: 9234038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidity: A sign of the times.
    Pivik RT
    J Psychiatry Neurosci; 1997 Mar; 22(2):97-8. PubMed ID: 9074302
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive functioning, family history of alcoholism, and antisocial behavior in female polydrug abusers.
    Rodríguez M
    Psychol Rep; 1993 Aug; 73(1):19-26. PubMed ID: 8367557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.